|
|
|
|
Longer Term Efficacy and Safety of F/TAF and F/TDF For HIV PrEP: DISCOVER Trial Week 96 Results
|
|
|
CROI 2020 March 9
Reported by Jules Levin
Onyema Ogbuagu1, Daniel Podzamczer2, Laura C. Salazar3, Keith Henry4, David M. Asmuth5, David Wohl6, Richard Gilson7, Yongwu Shao8, Ramin Ebrahimi8, Christoph Carter8, Moupali Das8, Scott McCallister8, Jason M. Brunetta9, Gitte Kronborg10, Christoph D. Spinner3
1Yale University, New Haven, CT; 2Hospital Universitario de Bellvitge, Barcelona, Spain; 3Technical University Munich, Munich, Germany; 4Hennepin Healthcare Research Institute, Minneapolis, MN; 5University of California Davis, Davis, CA; 6University of North Carolina at Chapel Hill, Chapel Hill, NC; 7University College London, London, UK; 8Gilead Sciences, Inc., Foster City, CA; 9Maple Leaf Medical Clinic, Toronto, ON, Canada; 10Hvidovre Hospital, Hvidovre, Denmark
|
|
|
|
|
|
|